Actively Recruiting
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
Led by Hoffmann-La Roche · Updated on 2026-02-18
500
Participants Needed
44
Research Sites
263 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will evaluate the physical impact of MS from participant's perspective, provide continued access to ocrelizumab and assess the safety and tolerability of ocrelizumab. From Protocol Version 6 onwards, treatment within this study will be limited to the currently approved doses of ocrelizumab, 600 milligrams (mg), intravenous (IV) infusion or 920 mg, subcutaneous (SC) injection.
CONDITIONS
Official Title
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must have been receiving ongoing ocrelizumab treatment in specified parent studies at the time of roll-over
- Participants must not have access to ocrelizumab treatment locally
- First dose in this extension study must be given no earlier than 5 months after last dose in parent study
- Negative urine pregnancy test within 24 hours before first dose for participants of childbearing potential
You will not qualify if you...
- Ocrelizumab treatment is commercially available and accessible in the participant's country
- Ocrelizumab is available through a Post Trial Access Program and accessible to the participant
- Permanent premature discontinuation of ocrelizumab during the parent study or before first dose in extension study
- Any condition that may interfere with safety interpretation or increase treatment risks as judged by investigator
- Current participation in any other therapeutic clinical trial besides the parent study
- Immunocompromised state
- Known active malignancy or under active monitoring for cancer recurrence
- Presence of other known neurological disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 44 locations
1
CHU Amiens Hopital Sud
Amiens Cedex1, France, 80054
Actively Recruiting
2
CHU de Besancon Hopital Jean Minjoz
Besançon, France, 25030
Actively Recruiting
3
Groupe Hospitalier Pellegrin
Bordeaux, France, 33076
Actively Recruiting
4
CHU Brest Hopital La Cavale Blanche
Brest, France, 29609
Actively Recruiting
5
Hopital neurologique Pierre Wertheimer - CHU Lyon
Bron, France, 69677
Actively Recruiting
6
CHU De Caen
Caen, France, 14033
Actively Recruiting
7
Hopital Gabriel Montpied CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63003
Withdrawn
8
CH St Vincent de Paul
Lille, France, 59000
Actively Recruiting
9
Hopital Gui de Chauliac
Montpellier, France, 34295
Actively Recruiting
10
Hopital Nord Laennec
Nantes, France, 44093
Actively Recruiting
11
Hôpital Pasteur
Nice, France, 06002
Actively Recruiting
12
GroupeHospitalo-Universitaire Caremeau
Nîmes, France, 30029
Actively Recruiting
13
Hopital de Hautepierre
Strasbourg, France, 67098
Actively Recruiting
14
NeuroPoint Gesellschaft fur vorbeugende Gesundheitspflege mbH
Ulm, Germany, 89073
Actively Recruiting
15
Studienzentrum Nordwest Dr med Joachim Springub Herr Wolfgang Schwarz
Westerstede, Germany, 26655
Actively Recruiting
16
Deutsche Klinik für Diagnostik
Wiesbaden, Germany, 65191
Actively Recruiting
17
Krasnoyarsk State Medical Academy
Krasnoyarsk, Krasnoyarsk Krai, Russia, 660022
Actively Recruiting
18
FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
Krasnoyarsk, Krasnoyarsk Krai, Russia, 660037
Actively Recruiting
19
City Clinical Hospital #24
Moscow, Moscow Oblast, Russia, 127015
Actively Recruiting
20
Federal center of brain research and neurotechnologies
Moskva, Moscow Oblast, Russia, 117997
Actively Recruiting
21
National Center of Social Significant Disease
Saint Petersburg, Sankt-Peterburg, Russia, 197110
Actively Recruiting
22
LLC Osnova
Saint Petersburg, Sankt-Peterburg, Russia, 197341
Actively Recruiting
23
N.P. Bechtereva Institute of the Human Brain
Saint Petersburg, Sankt-Peterburg, Russia, 197376
Actively Recruiting
24
City Hospital #40 of Kurortniy Administrative District
Saint Petersburg, Sankt-Peterburg, Russia, 197706
Actively Recruiting
25
SHI Sverdlovsk Regional Clinical Hospital #1
Yekaterinburg, Sverdlovsk Oblast, Russia, 620102
Actively Recruiting
26
Vertebronevrologiya LLC
Kazan', Tatarstan Republic, Russia, 420043
Actively Recruiting
27
Ulyanovsk Regional Clinical Hospital
Ulyanovsk, Ulyanovsk Oblast, Russia, 432063
Actively Recruiting
28
Center of Cardiology and Neurology
Kirov, Russia, 610007
Actively Recruiting
29
Regional clinical hospital named after prof. S.V. Ochapovsky
Krasnodar, Russia, 350086
Actively Recruiting
30
FSBIH Siberian Regional Medical Centre of FMBA of Russia
Novosibirsk, Russia, 630007
Actively Recruiting
31
Perm SMA n.a. academ. E.A. Vagner
Perm, Russia, 614990
Actively Recruiting
32
5th Cherkasy City Center of Primary Health Care
Cherkasy, Ukraine, 18029
Actively Recruiting
33
Mun.Med.Proph.Inst.?Chernihiv Reg.Hosp.?
Chernihiv, Ukraine, 14029
Actively Recruiting
34
Bukovinsky SMU RMI Chernivtsi RCH
Chernivtsi, Ukraine, 58002
Actively Recruiting
35
SI USSRI of Medical and Social Problems of Disabilities of MOHU
Dnipro, Ukraine, 49027
Actively Recruiting
36
Regional Clinical Hospital
Ivano-Frankivsk, Ukraine, 76008
Actively Recruiting
37
St.In.Inst. of Neurol.Psych.and Narcol.of the AMSU
Kharkiv, Ukraine, 61068
Actively Recruiting
38
Medical Center Dopomoga Plus
Kyiv, Ukraine, 02123
Actively Recruiting
39
Medical Center of Private Execution First Private Clinic
Kyiv, Ukraine, 03037
Actively Recruiting
40
Volyn Regional Clinical Hospital
Lutsk, Ukraine, 43005
Actively Recruiting
41
Lvivska oblasna tsentralna likarnia
Lviv, Ukraine, 79010
Actively Recruiting
42
Medical Clinical Research Center of Medical Center LLC Health Clinic
Vinnytsi, Ukraine, 21009
Actively Recruiting
43
LCC "Medical center "Unimed"
Zaporizhzhia, Ukraine, 69035
Actively Recruiting
44
Municipal Non-profit Enterprise Zaporizhzhya Regional Hospital Zaporizhzhya Regional Council
Zaporizhzhia, Ukraine, 69600
Actively Recruiting
Research Team
R
Reference Study ID Number: MN45053 https://forpatients.roche.com/
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here